Carl June

Type: Person
Name: Carl June
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

UPenn, Wistar Institute to collaborate on $12 million SPORE grant

The Wistar Institute has announced that Meenhard Herlyn, DVM, DSc , will be the principal investigator on a $12.1 million Special Program of Research Excellence grant from the National Cancer Institute.Under the grant, Wistar and the University of Pennsylvania ... [Published Orthopedics Today - Sep 19 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Novartis, University Of Pennsylvania To Build Center For CAR Research

By Estel Grace MasangkayNovartis and the University of Pennsylvania announced their plans to build the Center for Advanced Cellular Therapeutics (CACT) on the Penn Medicine campus in Philadelphia.The center will be dedicated to advancing research in Chimeric ... [Published Bioresearch Online - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

CAR T Cells: A Look Under the Hood and Down the Road

Editor's Note: Cancer immunotherapy is among the fastest-growing areas of oncology research, but it leaves many oncologists scratching their heads. The deluge of promising data in immunotherapy means it is worth the effort to catch up on the science. ... [Published General Medicine eJournal - Sep 16 2014]
First reported Sep 11 2014 - Updated Sep 12 2014 - 1 reports

Novartis commits $20M to back a new CAR-T research center at Penn

With a lead chimeric antigen receptor program holding on to a breakthrough drug designation at the FDA and Penn's Carl June grabbing headlines for the data his team is seeing among cancer victims, their big pharma backer Novartis ($NVS) is contributing ... [Published FierceBiotech - Sep 11 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Three Biotech Companies With Disruptive UPenn Technologies Nearing Major Catalyst

The University of Pennsylvania (UPenn) is one of America’s most premiere Ivy League research universities. Its place as a home of innovation can be traced back to its founder Benjamin Franklin who advocated an educational program that focused as much ... [Published Benzinga.com - Aug 19 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

The Alliance for Regenerative Medicine Holds Fourth Annual Partnering Forum at the Meeting on the Mesa - October 7 and 8

Meeting Will Include Plenary Sessions on Latest Developments in Both Gene and Cell Therapy; UPenn's Carl June, M.D. Featured Speaker at Program's Public Forum ... [Published Marketwire - Breaking News Releases - Aug 05 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Lexington grad's ride marks 30 cancer-free years

MANSFIELD — Lexington graduate John Robinson was 14 when he was diagnosed with acute lymphocytic leukemia and told he had only a 35 percent chance of survival.A persistent nosebleed during summer camp in 1984 had alerted doctors.He went through the usual ... [Published Mansfield News Journal - Jun 26 2014]
First reported Jun 09 2014 - Updated Jun 10 2014 - 1 reports

Immunotherapies: The New Hope for Cancer Treatment

Ben ComerDespite a steady stream of new, highly-targeted cancer therapies entering the market in recent years, most patients strugglingagainst the disease aren't living much longer. In terms of disease progression and death, health outcomes in oncology ... [Published Pharmaceutical Executive - Jun 09 2014]
First reported Jun 04 2014 - Updated Jun 04 2014 - 1 reports

Leukemia researcher tapped for 2014 Taubman Prize

ANN ARBOR, Mich.Carl JuneThe research is considered a landmark breakthrough in treating blood cancers that have stopped responding to conventional therapies, or for patients who are not candidates for bone marrow transplants, which carry a high mortality ... [Published PR Newswire - Jun 04 2014]
First reported Jun 03 2014 - Updated Jun 04 2014 - 1 reports

Immunotherapy: A Promising New Approach to Treating Cancer with Carl June MD

<a style="font-size: 15px; font-weight: bold;font-decoration: none;" href="http://www.youtube.com/watch?v=WcnzetT4ezY&feature=youtube_gdata"&gt;Immunotherapy: A Promising New Approach to Treating Cancer with Carl June MD Visit: http://www.uctv.tv/) ... [Published UC Television - YouTube - Jun 03 2014]
First reported May 17 2014 - Updated May 17 2014 - 1 reports

Dr. Carl June: "Putting the Immune System on Steroids"

A professor of immunology at the University of Pennsylvania’s Perelman School of Medicine, Dr. Carl June gave a captivating description of the promise of immunology therapy during a presentation Wednesday, May 14 at UC San Diego. For Dr. Carl June, lead ... [Published PRWeb - May 17 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

What's the Latest in Cancer Therapy? Immunotherapy Research Leader Dr. Carl June to Speak at UC San Diego, May 14

Immunotherapy is one of the most exciting new approaches to treating cancer. Dr. Carl June will discuss his findings May 14 as featured speaker at UC San Diego. A world leader in immunotherapy, Carl June, will discuss the emergence of a new form of targeted ... [Published PRWeb - Apr 04 2014]

Quotes

"The past five years have been a time of explosive, exciting progress in the field of cancer cellular therapy," said June in a statement. "the results we've seen among the leukemia patients we've treated using our 'hunter' cells have accelerated our expectations for the potential of these new therapies. today, many of those brave patients are thriving, and through our work in the cact, we hope to offer that chance to patients with many other types of cancers."

More Content

All (17) | News (11) | Reports (0) | Blogs (6) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
UPenn, Wistar Institute to collaborate on $12 m... [Published Orthopedics Today - Sep 19 2014]
Novartis, University Of Pennsylvania To Build C... [Published Bioresearch Online - Sep 16 2014]
CAR T Cells: A Look Under the Hood and Down the... [Published General Medicine eJournal - Sep 16 2014]
Novartis commits $20M to back a new CAR-T resea... [Published FierceBiotech - Sep 11 2014]
Three Biotech Companies With Disruptive UPenn T... [Published Benzinga.com - Aug 19 2014]
The Alliance for Regenerative Medicine Holds Fo... [Published Marketwire - Breaking News Releases - Aug 05 2014]
Lexington grad's ride marks 30 cancer-free years [Published Mansfield News Journal - Jun 26 2014]
Immunotherapies: The New Hope for Cancer Treatment [Published Pharmaceutical Executive - Jun 09 2014]
Leukemia researcher tapped for 2014 Taubman Prize [Published PR Newswire - Jun 04 2014]
Immunotherapy: A Promising New Approach to Trea... [Published UC Television - YouTube - Jun 03 2014]
Dr. Carl June: "Putting the Immune System on St... [Published PRWeb - May 17 2014]
Bryn Mawr couple to be honored as recipients of... [Published Main Line Times - May 06 2014]
What's the Latest in Cancer Therapy? Immunother... [Published PRWeb - Apr 04 2014]
Genetically Engineered T Cells Used as a Weapon... [Published Singularity Hub - Mar 23 2014]
The search for a cure for AIDS: If it ain’t broke… [Published The Economist - Science & Technology - Mar 06 2014]
Gene-editing method tackles HIV in first clinic... [Published 3quarksdaily - Mar 06 2014]
Deals Of The Week: Novartis Places Bid To Domin... [Published The IN VIVO Blog - Feb 21 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
The Alliance for Regenerative Medicine Holds Fo... [Published Marketwire - Breaking News Releases - Aug 05 2014]
Meeting Will Include Plenary Sessions on Latest Developments in Both Gene and Cell Therapy; UPenn's Carl June, M.D. Featured Speaker at Program's Public Forum ...
Immunotherapy: A Promising New Approach to Trea... [Published UC Television - YouTube - Jun 03 2014]
<a style="font-size: 15px; font-weight: bold;font-decoration: none;" href="http://www.youtube.com/watch?v=WcnzetT4ezY&feature=youtube_gdata"&gt;Immunotherapy: A Promising New Approach to Treating Cancer with Carl June MD Visit: http://www.uctv.tv/) ...
Genetically Engineered T Cells Used as a Weapon... [Published Singularity Hub - Mar 23 2014]
Carl June and his colleagues at the University of Pennsylvania have been making waves since they published some successes fighting leukemia with a revolutionary new method. They removed patients’ T cells and genetically modified them to target and ...
The search for a cure for AIDS: If it ain’t broke… [Published The Economist - Science & Technology - Mar 06 2014]
To your very good health, sir!GENE therapy usually works by repairing a broken gene or creating a new one where none previously existed. Breaking a working gene to effect a cure is a novel approach. That, though, is what Carl June of the University ...
Gene-editing method tackles HIV in first clinic... [Published 3quarksdaily - Mar 06 2014]
Sarah Reardon in Nature: A clinical trial has shown that a gene-editing technique can be safe and effective in humans. For the first time, researchers used enzymes called zinc-finger nucleases (ZFNs) to target and destroy a gene in the immune cells ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.